1. Home
  2. TOWN vs NVAX Comparison

TOWN vs NVAX Comparison

Compare TOWN & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TowneBank

TOWN

TowneBank

HOLD

Current Price

$33.70

Market Cap

2.7B

Sector

Finance

ML Signal

HOLD

Logo Novavax Inc.

NVAX

Novavax Inc.

HOLD

Current Price

$6.83

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TOWN
NVAX
Founded
1998
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
1.1B
IPO Year
1999
1995

Fundamental Metrics

Financial Performance
Metric
TOWN
NVAX
Price
$33.70
$6.83
Analyst Decision
Hold
Hold
Analyst Count
1
8
Target Price
$41.00
$9.75
AVG Volume (30 Days)
378.7K
3.1M
Earning Date
01-21-2026
11-06-2025
Dividend Yield
3.21%
N/A
EPS Growth
11.95
N/A
EPS
2.23
2.07
Revenue
$766,599,000.00
$1,064,651,000.00
Revenue This Year
$23.63
$58.91
Revenue Next Year
$29.20
N/A
P/E Ratio
$15.09
$3.30
Revenue Growth
14.10
20.27
52 Week Low
$29.43
$5.01
52 Week High
$38.01
$11.55

Technical Indicators

Market Signals
Indicator
TOWN
NVAX
Relative Strength Index (RSI) 42.59 47.95
Support Level $33.33 $6.36
Resistance Level $36.15 $7.00
Average True Range (ATR) 0.58 0.22
MACD -0.18 0.07
Stochastic Oscillator 9.97 66.67

Price Performance

Historical Comparison
TOWN
NVAX

About TOWN TowneBank

Towne Bank is a financial services company that places special emphasis on serving the financial needs of individuals, commercial enterprises, and professionals, offering retail and commercial banking services to numerous markets in Virginia and North Carolina. The company has three reportable segments: the Banking Segment provides loan and deposit services to retail and commercial customers and provides commercial mortgage brokerage services and investment and asset management services, and the Realty Segment provides residential real estate services and mortgage loans. It also provides resort property management and residential and commercial title insurance, and the Insurance Segment provides a wide array of insurance products, including property, casualty, life, and health insurance.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

Share on Social Networks: